Phase I study of LY2603618, a CHK1 inhibitor, in combination with gemcitabine in Japanese patients with solid tumors. (Q53374074)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I study of LY2603618, a CHK1 inhibitor, in combination with gemcitabine in Japanese patients with solid tumors. |
scientific article |
Statements
Phase I study of LY2603618, a CHK1 inhibitor, in combination with gemcitabine in Japanese patients with solid tumors. (English)
1 reference
Toshihiko Doi
1 reference
Takayuki Yoshino
1 reference
Kohei Shitara
1 reference
Nobuaki Matsubara
1 reference
Nozomu Fuse
1 reference
Yoichi Naito
1 reference
Kazunori Uenaka
1 reference
Takashi Nakamura
1 reference
Scott M Hynes
1 reference
Aimee Bence Lin
1 reference
1 November 2015
1 reference
26
1 reference
10
1 reference
1043-1053
1 reference
Identifiers
1 reference